MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis

Experimental and Molecular Pathology

Volumn 91, Issue 2, 2011, Pages 603-607

  Wanninger, Josef ^a   Walter, Roland ^a   Bauer, Sabrina ^a   Eisinger, Kristina ^a   Schäffler, Andreas ^a   Dorn, Christoph ^a   Weiss, Thomas S ^a   Hellerbrand, Claus ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Extracellular matrix; Hepatic steatosis; Liver fibrosis; Paigen diet

Indexed keywords

ADIPONECTIN; GELATIN; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPONECTIN GENE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; FIBRINOLYSIS; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER FIBROSIS; MALE; MATRIX METALLOPROTEINASE 9 GENE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE 1 GENE; ZYMOGRAPHY;

ADIPONECTIN; AGED; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; HEPATOCYTES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MIDDLE AGED; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

MURINAE; MUS; RODENTIA;

EID: 79961120951     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.07.001     Document Type: Article

References (30)

1. Benaitreau D., et al. Effects of adiponectin on human trophoblast invasion. J. Endocrinol. 2010, 207:45-53.
2. D'Amico F., et al. Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection. Acta Histochem. 2010, 112:474-481.
3. Dorn C., et al. Expression of fatty acid synthase in nonalcoholic fatty liver disease. Int. J. Clin. Exp. Pathol. 2010, 3:505-514.
4. Esposito E., et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J. Nutr. 2009, 139:905-911.
5. Garciade Leon Mdel C., et al. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. Exp. Mol. Pathol. 2006, 80:97-108.
6. Hemmann S., et al. Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J. Hepatol. 2007, 46:955-975.
7. Hui J.M., et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology 2004, 40:46-54.
8. Illemann M., et al. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol. Cancer Res. 2006, 4:293-302.
9. Kang E.H., et al. Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res. Ther. 2010, 12:R231.
10. Kumada M., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109:2046-2049.
11. Lichtinghagen R., et al. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin. Sci. 2003, 105:373-382. (Lond).
12. Ljumovic D., et al. Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases. Clin. Chim. Acta 2004, 349:203-211.
13. Lo L., et al. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol. 2011, 55:435-444.
14. Matsuzawa N., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007, 46:1392-1403.
15. Nishina P.M., et al. Effects of dietary fats from animal and plant sources on diet-induced fatty streak lesions in C57BL/6J mice. J. Lipid Res. 1993, 34:1413-1422.
16. Nishina P.M., et al. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 1990, 31:859-869.
17. Park H.Y., et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp. Mol. Med. 2001, 33:95-102.
18. Schaffler A., et al. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005, 2:273-280.
19. Schattenberg J.M., Galle P.R. Animal models of non-alcoholic steatohepatitis: of mice and man. Dig. Dis. 2010, 28:247-254.
20. Targher G., et al. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin. Endocrinol. 2004, 61:700-703. (Oxf).
21. Thasler W.E., et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the Academic and Commercial Sector in Germany. Cell Tissue Bank. 2003, 4:49-56.
22. Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig. Dis. 2010, 28:179-185.
23. Tomita K., et al. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 2006, 55:415-424.
24. Tong K.M., et al. Adiponectin increases MMP-3 expression in human chondrocytes through AdipoR1 signaling pathway. J. Cell. Biochem. 2011, 112:1431-1440.
25. Velayudham A., et al. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009, 49:989-997.
26. Vergnes L., et al. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 2003, 278:42774-42784.
27. Wanninger J., et al. Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes. FEBS Lett. 2011, 585:1338-1344.
28. Wanninger J., et al. Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. Biochim Biophys Acta 2011, 1811:626-633.
29. Wobser H., et al. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res. 2009, 19:996-1005.
30. Xu A., et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Investig. 2003, 112:91-100.